ACTIV-3/Therapeutics for Inpatients with COVID-19 (TICO) Study Group, Nielsen, H & Thisted, R K 2022, ' Efficacy and safety of two neutralising monoclonal antibody therapies, sotrovimab and BRII-196 plus BRII-198, for adults hospitalised with COVID-19 (TICO) : a randomised controlled trial ', The Lancet. Infectious diseases, vol. 22, no. 5, pp. 622-635 . https://doi.org/10.1016/S1473-3099(21)00751-9 ACTIV-3/Therapeutics for Inpatients with COVID-19 (TICO) Study Group, Johansen, I S & Larsen, L 2022, ' Efficacy and safety of two neutralising monoclonal antibody therapies, sotrovimab and BRII-196 plus BRII-198, for adults hospitalised with COVID-19 (TICO) : a randomised controlled trial ', The Lancet Infectious Diseases, vol. 22, no. 5, pp. 622-635 . https://doi.org/10.1016/S1473-3099(21)00751-9 The Lancet. Infectious Diseases
Rastoder, E, Sivapalan, P, Eklöf, J, Saeed, M I, Jordan, A S, Meteran, H, Tønnesen, L, Biering-Sørensen, T, Løkke, A, Seershol, N, Nielsen, T L, Carlsen, J, Janner, J, Godtfredsen, N, Bødtger, U, Laursen, C, Hilberg, O, Knop, F K, Priemé, H, Gottlieb, V, Wilcke, J T & Jensen, J U S 2021, ' Systemic corticosteroids and the risk of venous thromboembolism in COPD patients: A nationwide study of 30.473 outpatients with severe-very severe COPD ', European Respiratory Journal. Supplement, vol. 58, no. suppl. 65, OA2590 . https://doi.org/10.1183/13993003.congress-2021.OA2590
Biomedicines Rastoder, E, Sivapalan, P, Eklöf, J, Saeed, M I, Jordan, A S, Meteran, H, Tønnesen, L, Biering-Sørensen, T, Løkke, A, Seersholm, N, Nielsen, T L, Carlsen, J, Janner, J, Godtfredsen, N, Bodtger, U, Laursen, C B, Hilberg, O, Knop, F K, Priemé, H, Ingebrigtsen, T S, Gottlieb, V, Wilcke, J T & Jensen, J U S 2021, ' Systemic corticosteroids and the risk of venous thromboembolism in patients with severe copd : A nationwide study of 30, 473 outpatients ', Biomedicines, vol. 9, no. 8, 874 . https://doi.org/10.3390/biomedicines9080874 Biomedicines, Vol 9, Iss 874, p 874 (2021) Volume 9 Issue 8